Data / Form D filings / Pierogi Therapeutics, Inc
Pierogi Therapeutics, Inc: Form D filing
Pierogi Therapeutics, Inc, a biotechnology company in Pittsburgh, PA, filed a Form D with the SEC in 2026. The latest, on June 17, 2026, reports $50,000 sold of a $4 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 5533 BEACON ST, Pittsburgh, PA, 15217
- Phone
- (502) 548-9920
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2025
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2139858
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 17, 2026 | New notice | $4,000,000 | $50,000 | $3,950,000 | 1 | Jun 9, 2026 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Samuel Benjamin Koby | Executive Officer, Director | Koby serves as CEO and a member of the Board of Directors. |
| Filipp Gusev | Executive Officer, Director | Gusev serves as CSO and member of the Board of Directors. |
Other biotechnology companies in Pennsylvania that filed recently
- BioLattice Ophthalmics, Inc, $1.8 million · Oct 28, 2026
- Myris Therapeutics, Inc. $500,000 · Oct 14, 2026
- Praeventix, Inc. $5.6 million · Sep 10, 2026
- Plowshare Therapies LLC $6.7 million · Aug 31, 2026
- Noveome Biotherapeutics, Inc. $6.8 million · Aug 27, 2026
- AlloTRx Bio Inc. $500,000 · Aug 24, 2026
Every Form D from the week of Jun 15, 2026 · All recent filings in Pennsylvania · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Pierogi Therapeutics, Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.